Scrip Regulatory Affairs
French regulatory reform: tough on trials, taxes and transparency
28 June 2011
Ian Schofield
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- French bill tightens up on safety and conflicts of interest, but not drug approval criteria
- French govt promises "culture shock" in drug regulation, while price cuts and levies loom
- French propose tougher measures for medtech post-Mediator
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
